We are thrilled to announce that we have acquired Orange Pharmaceutical in Kenya. This strategic move strengthens our position amongst the top players in the Kenyan pharmaceutical market. By integrating Orange Pharmaceutical’s expertise, we will enhance our product portfolio and better serve the healthcare needs of the Kenyan population. This acquisition demonstrates our commitment to investing in the African healthcare sector and supporting local economies.
We look forward to contributing to developing Kenya’s healthcare infrastructure and improving access to essential medicines. This milestone sets the stage for further growth and advancements in the pharmaceutical industry, benefiting the entire healthcare ecosystem and, particularly, the people of Kenya.
